Synopsis
Synopsis
0
VMF
0
Canada
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (1-hydroxy-3-(methylpentylamino)propylidene)bisphosphonate
2. 1-hydroxy-3-(methylpentylamino)propylidenebisphosphonate
3. Bm 21.0955
4. Bm 210955
5. Bm-21.0955
6. Bm-210955
7. Bm21.0955
8. Bm210955
9. Bondronat
10. Boniva
11. Bonviva
12. Ibandronate
13. Ibandronate Sodium Anhydrous
14. Ibandronic Acid
15. Ibandronic Acid, Sodium Salt, Monohydrate
16. Rpr 102289a
17. Rpr-102289a
18. Rpr102289a
1. 138844-81-2
2. Bondronat
3. Ibandronate Sodium Salt
4. Boniva
5. Ibandronate (sodium)
6. Sodium Ibandronate
7. Ibandronate Sodium Anhydrous
8. Bonviva
9. 23y0b94e49
10. (1-hydroxy-3-(methylpentylamino)propylidene)bisphosphonic Acid Sodium
11. Sodium;hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphinate
12. Phosphonic Acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-, Monosodium Salt
13. Bm 21.0955na
14. Ncgc00167428-01
15. Bm-21.0955
16. Unii-23y0b94e49
17. Dsstox_cid_26618
18. Dsstox_rid_81770
19. Dsstox_gsid_46618
20. Schembl1030768
21. Chembl1201008
22. Dtxsid8046618
23. Hy-b0515b
24. Hms3263m08
25. Hms3714g19
26. Sodium Ibandronate Anhydrous
27. Bcp22744
28. Ibandronate Sodium [who-dd]
29. Tox21_112432
30. Tox21_501103
31. Mfcd07197214
32. Akos026750153
33. Bcp9000767
34. Ccg-220679
35. Ccg-222407
36. Lp01103
37. Ibandronic Acid Sodium Salt [mi]
38. Ncgc00261788-01
39. Cas-138844-81-2
40. Ft-0670252
41. S0877
42. H11437
43. Ibandronate Sodium Salt, >=97% (nmr), Solid
44. J-007183
45. Q27253790
46. (1-hydroxy-3-(methyl(pentyl)amino)propane-1,1-diyl)diphosphonic Acid Monosodium Salt
Molecular Weight | 341.21 g/mol |
---|---|
Molecular Formula | C9H22NNaO7P2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 341.07692032 g/mol |
Monoisotopic Mass | 341.07692032 g/mol |
Topological Polar Surface Area | 141 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 377 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Boniva |
PubMed Health | Ibandronate |
Drug Classes | Calcium Regulator |
Drug Label | BONIVA (ibandronate sodium) is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption. The chemical name for ibandronate sodium is 3-(N-methyl-N-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid, monosodium salt, mon... |
Active Ingredient | Ibandronate sodium |
Dosage Form | Injectable; Tablet |
Route | Intravenous; Oral |
Strength | eq 3mg base/3ml; eq 150mg base |
Market Status | Prescription |
Company | Hoffmann La Roche; Roche |
2 of 4 | |
---|---|
Drug Name | Ibandronate sodium |
Drug Label | BONIVA (ibandronate sodium) is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption. The chemical name for ibandronate sodium is 3-(N-methyl-N-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid, monosodium salt, mon... |
Active Ingredient | Ibandronate sodium |
Dosage Form | Tablet; Injectable |
Route | injection; oral; Oral; Intravenous |
Strength | 2.5mg; 1mg; eq 150mg base; eq 3mg base/3ml |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Teva Parenteral; Apotex; Sun Pharm Inds; Watson Labs; Emcure Pharms; Mutual Pharm; Cobalt Labs; Sagent Pharms; Dr Reddys Labs; Agila Speclts; Orchid Hlthcare |
3 of 4 | |
---|---|
Drug Name | Boniva |
PubMed Health | Ibandronate |
Drug Classes | Calcium Regulator |
Drug Label | BONIVA (ibandronate sodium) is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption. The chemical name for ibandronate sodium is 3-(N-methyl-N-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid, monosodium salt, mon... |
Active Ingredient | Ibandronate sodium |
Dosage Form | Injectable; Tablet |
Route | Intravenous; Oral |
Strength | eq 3mg base/3ml; eq 150mg base |
Market Status | Prescription |
Company | Hoffmann La Roche; Roche |
4 of 4 | |
---|---|
Drug Name | Ibandronate sodium |
Drug Label | BONIVA (ibandronate sodium) is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption. The chemical name for ibandronate sodium is 3-(N-methyl-N-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid, monosodium salt, mon... |
Active Ingredient | Ibandronate sodium |
Dosage Form | Tablet; Injectable |
Route | injection; oral; Oral; Intravenous |
Strength | 2.5mg; 1mg; eq 150mg base; eq 3mg base/3ml |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Teva Parenteral; Apotex; Sun Pharm Inds; Watson Labs; Emcure Pharms; Mutual Pharm; Cobalt Labs; Sagent Pharms; Dr Reddys Labs; Agila Speclts; Orchid Hlthcare |
Treatment of osteoporosis in postmenopausal women at increased risk of fracture (see section 5. 1). A reduction in the risk of vertebral fractures has been demonstrated, efficacy on femoral neck fractures has not been established.
Bondronat is indicated for:
- prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases;
- treatment of tumour-induced hypercalcaemia with or without metastases.
Bone Density Conservation Agents
Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)
M05BA06
M05BA06
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-12-12
Pay. Date : 2016-06-21
DMF Number : 25638
Submission : 2011-12-29
Status : Active
Type : II
Certificate Number : R0-CEP 2022-073 - Rev 00
Issue Date : 2023-02-20
Type : Chemical
Substance Number : 2771
Status : Valid
Registration Number : 303MF10116
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2021-07-20
Latest Date of Registration :
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2019-08-02
Registration Number : No. 2417-3-ND(1)
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm :
NDC Package Code : 55111-872
Start Marketing Date : 2007-04-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20494
Submission : 2007-04-30
Status : Inactive
Type : II
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Certificate Number : R0-CEP 2023-077 - Rev 00
Issue Date : 2023-06-30
Type : Chemical
Substance Number : 2771
Status : Valid
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2019-08-02
Registration Number : No. 2417-3-ND(1)
Manufacturer Name : Pharmaceutical Works Polpharma S.A.
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20605
Submission : 2007-06-06
Status : Active
Type : II
Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20422
Submission : 2007-04-09
Status : Active
Type : II
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
GDUFA
DMF Review : Complete
Rev. Date : 2016-12-12
Pay. Date : 2016-06-21
DMF Number : 25638
Submission : 2011-12-29
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20494
Submission : 2007-04-30
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20525
Submission : 2007-05-11
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-04-10
Pay. Date : 2013-01-04
DMF Number : 20393
Submission : 2007-03-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20427
Submission : 2007-04-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20391
Submission : 2007-03-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20411
Submission : 2007-04-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20422
Submission : 2007-04-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15429
Submission : 2001-05-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20605
Submission : 2007-06-06
Status : Active
Type : II
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Ibandronate Sodium Monohydrate, Type I
Certificate Number : R0-CEP 2023-077 - Rev 00
Status : Valid
Issue Date : 2023-06-30
Type : Chemical
Substance Number : 2771
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Ibandronate Sodium Monohydrate
Certificate Number : R0-CEP 2022-073 - Rev 00
Status : Valid
Issue Date : 2023-02-20
Type : Chemical
Substance Number : 2771
Ibandronate Sodium Monohydrate
Certificate Number : CEP 2022-338 - Rev 00
Status : Valid
Issue Date : 2024-06-21
Type : Chemical
Substance Number : 2771
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Ibandronate Sodium Monohydrate
Registration Number : 303MF10116
Registrant's Address : 19 Pellinska Str. 83-200 Starogard Gdanski POLAND
Initial Date of Registration : 2021-07-20
Latest Date of Registration : 2021-07-20
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Ibandronate Sodium Form Beta IH/Ibandronate Sodium Monohydrate IH
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm : Chemical Technical Operations Unit-VI, APIIC Industrial Estate, Pydibhimavaram V...
Date of Issue : 2022-02-02
Valid Till : 2024-06-07
Written Confirmation Number : WC-0317
Address of the Firm : Plot.No 43 & 44, IDA Phase-II, Pashamylaram, Patancheru Mandal, Medak Disctrict,...
Date of Issue : 2020-11-27
Valid Till : 2021-06-07
Written Confirmation Number : WC-0317A2
Address of the Firm : Plot.No 43 & 44, IDA Phase-II, Pashamylaram, Patancheru Mandal, Medak Disctrict,...
Ibandronate Sodium Monohydrate IH
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm : D-24 and D24/1 MIDC Kurkumbh Tal. Daund, Dist Pune 413 802, Maharashtra State
Date of Issue : 2022-03-04
Valid Till : 2024-12-16
Written Confirmation Number : WC-0336
Address of the Firm : T-108 MIDC Tarapur, Boisar Dist Thane 401506 Maharashtra
Ibandronate Sodium Monohydrate (IH)
Date of Issue : 2019-06-26
Valid Till : 2022-06-25
Written Confirmation Number : WC-0014
Address of the Firm : Mekaguda (V) kothur (M) Mahabood nagar Dist, Telangana State India
Ibandronic Acid Monosodium Monohydrate(IH)
Date of Issue : 2022-06-08
Valid Till : 2025-07-25
Written Confirmation Number : WC-0159
Address of the Firm : A-7/A-8, MIDC, Ahmednagar-414 111, Maharashtra State
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registrant Name : Hwail Pharmaceutical Co., Ltd.
Registration Date : 2013-01-21
Registration Number : Number 2417-3-ND
Manufacturer Name : Pharmaceutical Works Polphar...
Manufacturer Address : 19, Pelplinska Str. 83-200 Starogard Gdanski, Poland
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Registrant Name : Wooshin Labotech Co., Ltd.
Registration Date : 2019-08-02
Registration Number : No. 2417-3-ND(1)
Manufacturer Name : Pharmaceutical Works Polphar...
Manufacturer Address : 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2015-01-12
Registration Number : Su730-1-ND
Manufacturer Name : Chongqing Shenghuaxi Pharmac...
Manufacturer Address : No.8, Jiangqiao Road, Nan'an District Chongqing, China
Registrant Name : Unimed Pharmaceutical Co., Ltd.
Registration Date : 2016-02-04
Registration Number : No. 4766-1-ND(4)
Manufacturer Name : Fleming Laboratories Limited
Manufacturer Address : Plot No. 152&160, Phase-V, IDA, Jeedimetla(V), Quthbullapur(M) Medchal-Malkajgiri Dis...
Registrant Name : Hiple Co., Ltd.
Registration Date : 2020-09-08
Registration Number : No. 4766-1-ND(5)
Manufacturer Name : Fleming Laboratories Limited
Manufacturer Address : Plot No. 152&160, Phase-V, IDA, Jeedimetla(V), Quthbullapur(M) Medchal-Malkajgiri Dis...
Registrant Name : Dongkwang Pharmaceutical Co., Ltd.
Registration Date : 2015-12-11
Registration Number : No. 4554-1-ND(6)
Manufacturer Name : Gador SA
Manufacturer Address : Calle 10, Fraccion Ⅲ, Parcela 7, Parque Industrial Pilar B1630CFA of the Province o...
Registrant Name : Korea United Pharmaceutical Co., Ltd.
Registration Date : 2016-08-24
Registration Number : No. 4554-1-ND(7)
Manufacturer Name : Gador. SA
Manufacturer Address : Calle 10, Fraccion Ⅲ, Parcela 7, Parque Industrial Pilar B1630CFA of the Province o...
Registrant Name : Good Pharma Co., Ltd.
Registration Date : 2015-11-27
Registration Number : No. 4554-1-ND(5)
Manufacturer Name : Gador SA
Manufacturer Address : Calle 10, Fraccion Ⅲ, Parcela 7, Parque Industrial Pilar B1630CFA of the Province o...
Registrant Name : Genewone Science Co., Ltd.
Registration Date : 2015-01-16
Registration Number : No. 4554-1-ND(4)
Manufacturer Name : Gador SA
Manufacturer Address : Calle 10, Fraccion Ⅲ, Parcela 7, Parque Industrial Pilar B1630CFA of the Province o...
Registrant Name : Dongkook Pharmaceutical Co., Ltd.
Registration Date : 2014-09-24
Registration Number : No. 4554-1-ND(3)
Manufacturer Name : Gador SA
Manufacturer Address : Calle 10, Fraccion III, Parcela 7, Parque Industrial Pilar B1630CFA of the Province o...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-897
Start Marketing Date : 2008-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-872
Start Marketing Date : 2007-04-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-270
Start Marketing Date : 2024-01-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14593-853
Start Marketing Date : 2022-02-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-4355
Start Marketing Date : 2016-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Bonviva is a medicine that contains the active substance ibandronic acid. It is available as tablets (150 mg) and as a solution for injection in a prefilled syringe (3 mg).
Lead Product(s): Ibandronate Sodium
Therapeutic Area: Musculoskeletal Brand Name: Bonviva
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: Taisho Pharmaceutical
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable November 24, 2022
Lead Product(s) : Ibandronate Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Taisho Pharmaceutical
Deal Size : Not Applicable
Deal Type : Not Applicable
Transfer and Future Marketing of Osteoporosis Agent Bonviva in Japan
Details : Bonviva is a medicine that contains the active substance ibandronic acid. It is available as tablets (150 mg) and as a solution for injection in a prefilled syringe (3 mg).
Product Name : Bonviva
Product Type : Small molecule
Upfront Cash : Not Applicable
November 24, 2022
3-(N-Methylpentylamino)-propionic Acid, Hydrochlor...
CAS Number : 625120-81-2
End Use API : Ibandronate Sodium
About The Company : Ramdev Chemicals Pvt. Ltd. is one of the fastest growing Active Pharmaceuticl Drugs, Drug Intermediates, Storage Fine Chemical Company in India which have speci...
3-(N-Methyl pentylamino) propionic acid hydrochlor...
CAS Number : 625120-81-2
End Use API : Ibandronate Sodium
About The Company : RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a...
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Ibandronat Zentiva Osteo
Dosage Form : Inj L?s
Dosage Strength : 3mg/3ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Ibandronate 2mg IV
Dosage Form : INJ
Dosage Strength : 2mg/2ml
Packaging : 2X1mg/2ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Ibandronate 6mg IV
Dosage Form : INJ
Dosage Strength : 6mg/6ml
Packaging : 6X1mg/6ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 1MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 6MG/6ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : EU Approved
Registration Country : Greece
Brand Name :
Dosage Form : Film Coated Tablet Once A Month
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Approved
Registration Country : Greece
Regulatory Info :
Registration Country : Italy
Brand Name : IBANDRONIC ACID THINK
Dosage Form : Film-Coated Tablets
Dosage Strength : 150 mg
Packaging : 1 UNIT 150 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Liquid Injection
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
RLD : No
TE Code : AB
Brand Name : IBANDRONATE SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Approval Date : 2012-03-19
Application Number : 78948
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AP
Brand Name : IBANDRONATE SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 3MG BASE/3ML
Approval Date : 2015-10-16
Application Number : 204222
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code :
Brand Name : IBANDRONATE SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 3MG BASE/3ML
Approval Date : 2014-09-02
Application Number : 203987
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AP
Brand Name : IBANDRONATE SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 3MG BASE/3ML
Approval Date : 2014-09-02
Application Number : 202235
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code : AB
Brand Name : IBANDRONATE SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Approval Date : 2017-10-31
Application Number : 206887
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : IBANDRONATE SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Approval Date : 2012-03-19
Application Number : 78998
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : IBANDRONATE SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Approval Date : 2012-08-15
Application Number : 78996
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : IBANDRONATE SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 3MG BASE/3ML
Approval Date : 2014-02-14
Application Number : 90853
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Brand Name : IBANDRONATE SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Approval Date : 2012-04-30
Application Number : 78997
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Brand Name : IBANDRONATE SODIUM
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Approval Date : 2012-03-19
Application Number : 78995
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Ibandronat Zentiva Osteo
Dosage Form : Inj L?s
Dosage Strength : 3mg/3ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : IBANDRONIC ACID THINK
Dosage Form : Film-Coated Tablets
Dosage Strength : 150 mg
Packaging : 1 UNIT 150 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : Bonviva
Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
Dosage Strength : 3 MG / 3 ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Bondronat
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 50 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Bondronat
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 50 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Italy
Brand Name : Ibandronic Acid
Dosage Form : Sodium Ibandronate 150Mg 1 Combined Oral Use
Dosage Strength : 1 cpr riv 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Switzerland
Brand Name : Ibandronat Sandoz
Dosage Form : Film-Coated Tablets
Dosage Strength : 150mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : IBANDRONIC ACID TEVA
Dosage Form : Film-Coated Tablets
Dosage Strength : 150 mg
Packaging : 1 UNIT 150 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : TABLET
Dosage Strength : 150MG
Packaging : 3 Or 28 Or 84 Tablets
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info :
Registration Country : Spain
Brand Name : Normon Ibandronic Acid 150Mg 1 Pills Coated Film Efg
Dosage Form : Film Coated Tablet
Dosage Strength : 150 Mg/Film Coated Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Capsule
Grade : Oral
Brand Name : Sodium Stearyl Fumarate G...
Application : Lubricants & Glidants
Excipient Details : Sodium Stearyl Fumarate is used as a lubricant in OSDs to reduce the friction and the adhesion. It also provides tablet strength & disintegration.
Pharmacopoeia Ref : USP, EP, ICH, Q7GMP
Technical Specs : NA
Ingredient(s) : Sodium Stearyl Fumarate
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90-...
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Direct Compression
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 310 g/l; Particle size- D10- 40 ?m, D50- 90 ?m, D90...
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90-...
Ingredient(s) : Lactose Monohydrate
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Not Available
Ingredient(s) : Croscarmellose Sodium
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 716 g/l, Bulk density- 599 g/l; Particle size- D10-50 ?m, D50- 120 ?m, D90-...
Ingredient(s) : Lactose Monohydrate
Excipients by Applications
Dosage Form : Tablet
Grade : Oral
Category : Coating Systems & Additives, Controlled & Modified Release
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Category : Coating Systems & Additives, Coloring Agents
Brand Name : Titanium dioxide PRETIOX AV01FG
Application : Coating Systems & Additives, Coloring Agents
Excipient Details : Titanium dioxide Pretiox AV01FG is used as a coloring and coating agent in oral solid dosage forms such as capsules, tablets, granules, and pellets.
Pharmacopoeia Ref : Fami-QS, Kosher, Halal, OHSAS ...
Technical Specs : Ti 59.95% and O 40.05%
Ingredient(s) : Titanium Dioxide
Brand Name : Sodium Stearyl Fumarate
Application : Lubricants & Glidants
Excipient Details : Sodium stearyl fumarate is used as a lubricant to reduce friction and adhesion in pharmaceutical solid oral formulations such as tablets and capsules.
Pharmacopoeia Ref : IH/BP/USP
Technical Specs : NA
Ingredient(s) : Sodium Stearyl Fumarate Excipient
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Category : Coating Systems & Additives, Coloring Agents
Grade : Not Available
Category : Coating Systems & Additives, Controlled & Modified Release
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : Film Forming Agent, Wet/Dry Granulation- Binder,Thickening & Suspension Agent, Non-Gelatin Capsule Manufacturing & Enteric Film Coating Systems
Pharmacopoeia Ref : USP, EP, and JP
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Brand Name : Hydroxypropyl Methyl Cellulose
Application : Coating Systems & Additives
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Emulsion, Tablet
Grade : Oral, Ophthalmic
Category : Disintegrants & Superdisintegrants, Emulsifying Agents, Film Formers & Plasticizers, Thickeners and Stabilizers
Brand Name : Hydroxypropyl Methyl Cellulose
Application : Disintegrants & Superdisintegrants, Emulsifying Agents, Film Formers & Plasticizers, Thickeners and Stabilizers
Excipient Details : Hydroxypropyl Methyl Cellulose is used as a film-former, disintegrant, thickener, and emulsifier in tablets, emulsions, and ophthalmic formulations.
Global Sales Information
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RX/OTC/DISCN : Class B
Dosage Form : Inj L?s
Dosage Strength : 3mg/3ml
Price Per Pack (Euro) : 44.11
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
RX/OTC/DISCN :
Dosage Form : Film-Coated Tablets
Dosage Strength : 150 mg
Price Per Pack (Euro) : 13
Published in :
Country : Italy
RX/OTC/DISCN :
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 150 mg
Price Per Pack (Euro) : 98.153
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 50 mg
Price Per Pack (Euro) : 296.74
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 50 mg
Price Per Pack (Euro) : 880.70
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 150 mg
Price Per Pack (Euro) : 35.882
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 150 mg
Price Per Pack (Euro) : 98.153
Published in :
Country : Norway
RX/OTC/DISCN :
Medical Valley Invest AB
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 150 mg
Price Per Pack (Euro) : 98.153
Published in :
Country : Norway
RX/OTC/DISCN :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Dosage Form : Coated Tablet
Dosage Strength : 150 Mg/Coated Tablet
Price Per Pack (Euro) : 13
Published in :
Country : Spain
RX/OTC/DISCN :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Dosage Form : Coated Tablet
Dosage Strength : 150 Mg/Coated Tablet
Price Per Pack (Euro) : 13
Published in :
Country : Spain
RX/OTC/DISCN :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
55
PharmaCompass offers a list of Ibandronate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibandronate Sodium manufacturer or Ibandronate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibandronate Sodium manufacturer or Ibandronate Sodium supplier.
PharmaCompass also assists you with knowing the Ibandronate Sodium API Price utilized in the formulation of products. Ibandronate Sodium API Price is not always fixed or binding as the Ibandronate Sodium Price is obtained through a variety of data sources. The Ibandronate Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ibandronate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ibandronate Sodium, including repackagers and relabelers. The FDA regulates Ibandronate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ibandronate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ibandronate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ibandronate Sodium supplier is an individual or a company that provides Ibandronate Sodium active pharmaceutical ingredient (API) or Ibandronate Sodium finished formulations upon request. The Ibandronate Sodium suppliers may include Ibandronate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Ibandronate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ibandronate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Ibandronate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Ibandronate Sodium DMFs exist exist since differing nations have different regulations, such as Ibandronate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ibandronate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Ibandronate Sodium USDMF includes data on Ibandronate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ibandronate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ibandronate Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ibandronate Sodium Drug Master File in Japan (Ibandronate Sodium JDMF) empowers Ibandronate Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ibandronate Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Ibandronate Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ibandronate Sodium suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ibandronate Sodium Drug Master File in Korea (Ibandronate Sodium KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ibandronate Sodium. The MFDS reviews the Ibandronate Sodium KDMF as part of the drug registration process and uses the information provided in the Ibandronate Sodium KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ibandronate Sodium KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ibandronate Sodium API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ibandronate Sodium suppliers with KDMF on PharmaCompass.
A Ibandronate Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Ibandronate Sodium Certificate of Suitability (COS). The purpose of a Ibandronate Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ibandronate Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ibandronate Sodium to their clients by showing that a Ibandronate Sodium CEP has been issued for it. The manufacturer submits a Ibandronate Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ibandronate Sodium CEP holder for the record. Additionally, the data presented in the Ibandronate Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ibandronate Sodium DMF.
A Ibandronate Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ibandronate Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ibandronate Sodium suppliers with CEP (COS) on PharmaCompass.
A Ibandronate Sodium written confirmation (Ibandronate Sodium WC) is an official document issued by a regulatory agency to a Ibandronate Sodium manufacturer, verifying that the manufacturing facility of a Ibandronate Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ibandronate Sodium APIs or Ibandronate Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Ibandronate Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Ibandronate Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ibandronate Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ibandronate Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ibandronate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ibandronate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ibandronate Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ibandronate Sodium suppliers with NDC on PharmaCompass.
Ibandronate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ibandronate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ibandronate Sodium GMP manufacturer or Ibandronate Sodium GMP API supplier for your needs.
A Ibandronate Sodium CoA (Certificate of Analysis) is a formal document that attests to Ibandronate Sodium's compliance with Ibandronate Sodium specifications and serves as a tool for batch-level quality control.
Ibandronate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Ibandronate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ibandronate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Ibandronate Sodium EP), Ibandronate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ibandronate Sodium USP).